High insulin costs come under fire on Capitol Hill

(HealthDay)—For many Americans, the cost of lifesaving insulin is simply too high, leading as many as one in four to ration the drug, experts testifying before the House Committee on Energy and Commerce said this week. The meeting focused primarily on defining the problem and exploring potential solutions, such as…